EUVIMEDEUVIMED entdecken
Crossref

‘Damning’ FDA inspection report undermines Alzheimer’s drug

Charles Piller

Science · 2024

DOI: 10.1126/science.adp1964 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, 2024. Verfasst von Charles Piller. Hauptthemen laut MEDLINE: Alzheimer Disease, Scientific Misconduct, Spiro Compounds, United States Food and Drug Administration. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inspectors faulted analyses of clinical trial samples by Hoau-Yan Wang for drug developer Cassava Sciences

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseScientific MisconductSpiro CompoundsUnited States Food and Drug AdministrationHumansUnited StatesClinical Trials as Topic

Substanzen

SimufilamSpiro Compounds

Zitieren

APA

Piller, C. (2024). ‘Damning’ FDA inspection report undermines Alzheimer’s drug. Science. https://doi.org/10.1126/science.adp1964

Vancouver

Piller C. ‘Damning’ FDA inspection report undermines Alzheimer’s drug. Science. 2024. doi:10.1126/science.adp1964

BibTeX
@article{Piller2024,
  author = {Piller, Charles},
  title = {‘Damning’ FDA inspection report undermines Alzheimer’s drug},
  journal = {Science},
  year = {2024},
  doi = {10.1126/science.adp1964}
}
Kostenlos starten →